Aggiudicatario
LFB BIOMEDICAMENTS
LES ULIS · FRA
Segui questa schedaAccount gratuito: ricevi un avviso quando un contratto qui scade.
Aggiudicazioni
23
Importo totale aggiudicato
1,1 Mld €
2 aggiudicazione/i congiunta/e conteggiata/e pro quota
Stazioni appaltanti
6
Settori
1
Gruppo: LFB BIOMEDICAMENTS
Reg. 491 371 167 00017
Contratti di questo aggiudicatario in scadenza
- 31 lug 2027dichiarataAbschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der LFB Biomedicaments zu Willfact und CevenfactaIKK classicLFB BIOMEDICAMENTS1 €
- 30 apr 2029dichiarataJ06BA02 - IG HUMAINES POLYVALENTES IV 10% PRETES A L'EMPLOI - STABILISE A LA GLYCINE + POLYSORBATEGIP RESAHLFB BIOMEDICAMENTS356.580 €
- 31 mag 2029dichiarataFACTEUR VIII HUMAIN PLASMATIQUEHospices Civils de LyonLFB BIOMEDICAMENTS23.849.005 €
- 31 mag 2029dichiarataFACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 15 nmHospices Civils de LyonLFB BIOMEDICAMENTS5.178.670 €
- 31 mag 2029dichiarataALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS12.956.735 €
- 31 mag 2029dichiarataALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS11.501.659 €
- 31 mag 2029dichiarataALBUMINE HUMAINE 200MG / ML (20%)Hospices Civils de LyonLFB BIOMEDICAMENTS10.859.806 €
- 31 mag 2029dichiarataALBUMINE HUMAINE 40MG / ML (4%)Hospices Civils de LyonLFB BIOMEDICAMENTS11.484.167 €
- 31 mag 2029dichiarataALBUMINE HUMAINE 50MG / ML (5%)Hospices Civils de LyonLFB BIOMEDICAMENTS3.380.883 €
- 31 mag 2029dichiarataALPHA-1 ANTITRYPSINE D'ORIGINE HUMAINE 33.33 MG / MLHospices Civils de LyonLFB BIOMEDICAMENTS37.930.100 €
- 31 mag 2029dichiarataFIBRINOGENE HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS, OCTAPHARMA FRANCE69.652.461 €
- 31 mag 2029dichiarataFACTEUR WILLEBRAND HUMAIN 100 UI / ML PURHospices Civils de LyonLFB BIOMEDICAMENTS58.157.024 €
- 31 mag 2029dichiarataFACTEUR XI HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS460.257.600 €
- 31 mag 2029dichiarataIG ANTITETANIQUE HUMAIN 250 UI / 2 MLHospices Civils de LyonLFB BIOMEDICAMENTS2.029.551 €
- 31 mag 2029dichiarataIG SPECIFIQUES ANTI HEPATITE B 100 UI / 1 MLHospices Civils de LyonLFB BIOMEDICAMENTS2.125.200 €
- 31 mag 2029dichiarataIG SPECIFIQUES ANTI HEPATITE B 500 UI / 5 MLHospices Civils de LyonLFB BIOMEDICAMENTS1.914.000 €
- 31 mag 2029dichiarataIG SPECIFIQUES ANTI HEPATITE B HUMAINE 5000 UI / 100 ML IVHospices Civils de LyonLFB BIOMEDICAMENTS14.491.404 €
- 31 mag 2029dichiarataIG POLYVALENTE HUMAINE IV 50MG / ML (5%) PAE - teneur en Ig A < 0.022 mg / mlHospices Civils de LyonLFB BIOMEDICAMENTS304.767.612 €
- 31 mag 2029dichiarataIG POLYVALENTE HUMAINE IV 50 MG/ML (5%) LYOPHILISEHospices Civils de LyonLFB BIOMEDICAMENTS56.145.276 €
Tutti i contratti in scadenza →